When adopting a sessile lifestyle, bacteria gain the adaptive ability to tolerate a wide range of antimicrobials, becoming increasingly resilient. In such cases, antimicrobial treatment of biofilm-driven infections may fail not necessarily due to resistance but rather through tolerance and target evasion. This course will provide up to date information on: the clinical relevance of microbial consortia; the role of quorum sensing in inter-microbial cooperation; in vitro biofilm assessment; infection prevention and control strategies for biofilm driven infections; clinical management of biofilm-associated infections.
Intended audience:
Medical doctors and pharmacists, nurses or other healthcare professionals with an MSc or PhD are eligible, provided they completed the basic module or have experience in IPC.
Objectives:
Course coordinator:
Organisers:
Certification:
Course organisers will monitor attendance. Only participants attending live sessions will be able to receive the certification.
Course Venue:
National Institute for Infectious Diseases
“Prof. Dr. Matei Balș” – HIV/AIDS Academy
No. 1 Dr. Calistrat Grozovici street
Bucharest, 021105, Romania and
and
Research Institute of the University of Bucharest (ICUB);
No. 1 Dr. Dimitrie Brândză street
Bucharest, 060102, Romania
Accreditation:
The organizers of the module have applied for European CME accreditation through EACCME.
Accommodation:
Accommodation is not included in the registration.
Registration details:
Registration fees include full access to the course, coffee breaks and lunches. Travel costs and accommodation are not included with either fee.
Registration
Registration was closed on 24.10.2024.
Attendance Grant application
Attendance grant application is not applicable
Registration for ESCMID Global 2026 in Munich is now open.
Register now to get the early registration fee and attend the world’s most eminent event in the field of infection.
Early registration expires 23:59 CET on 11th of February.